Pfizer-BioNTech | The Business Standard
Skip to main content
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Friday
June 20, 2025

Sign In
Subscribe
  • Latest
  • Epaper
  • Economy
    • Banking
    • Stocks
    • Industry
    • Analysis
    • Bazaar
    • RMG
    • Corporates
    • Aviation
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
FRIDAY, JUNE 20, 2025

Pfizer-BioNTech

A woman holds a small bottle labelled with a "Coronavirus Covid-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
Coronavirus chronicle

FDA says benefits outweigh risks for Pfizer/BioNTech Covid-19 vaccine in children

Both the Pfizer/BioNTech and Moderna Inc vaccines have been linked to rare cases of heart inflammation called myocarditis, especially in young men

Photo: Collected.
Coronavirus chronicle

Immunity from Pfizer vaccine wanes after two months: New studies

Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS/Dado Ruvic/Illustration
Covid-19 in Bangladesh

Pfizer says third dose of Covid-19 vaccine boosts protection against Delta variant

A health worker prepares a dose of vaccine at Suvarnabhumi Airport, Bangkok, Thailand, April 5, 2021. Photo: Reuters
Coronavirus chronicle

EU clears Pfizer-BioNTech Covid-19 vaccine for adolescents

Hong Kong says initial investigation of BioNTech vaccines shows no 'obvious systemic factors'
Coronavirus chronicle

Hong Kong says initial investigation of BioNTech vaccines shows no 'obvious systemic factors'

Malaysia's Prime Minister Muhyiddin Yassin receives the first dose of Pfizer-BioNTech Covid-19 vaccine at a clinic in Putrajaya, Malaysia February 24, 2021. Malaysia's Information Department/Muzzafar Kasim/Handout via REUTERS
Coronavirus chronicle

Malaysia launches Covid-19 vaccination drive as PM gets first shot

FILE PHOTO: The headquarters of biopharmaceutical company BioNTech are seen in Mainz, Germany July 31, 2018. REUTERS/Ralph Orlowski
Coronavirus chronicle

BioNTech says offering 50 mln needles to extract more vaccine doses

A bottle of Pfizer/BioNTech vaccine against the coronavirus disease (Covid-19) is pictured as the first batch is being defrosted at the Gasthuisberg hospital in Leuven, Belgium December 27, 2020. Fred Sierakowski/Pool via REUTERS
Coronavirus chronicle

Pfizer-BioNTech agree to supply WHO co-led Covid-19 vaccine scheme - sources

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net